Twist Bioscience Corporation (TWST) Q1 2026 Earnings Call February 2, 2026 8:00 AM EST
Company Participants
Angela Bitting – Chief Corporate Responsibility Officer & Senior VP of Corporate Affairs
Emily Leproust – Co-Founder, Board Chair & CEO
Patrick Finn – President & COO
Adam Laponis – Chief Financial Officer
Conference Call Participants
Matthew Larew – William Blair & Company L.L.C., Research Division
Subhalaxmi Nambi – Guggenheim Securities, LLC, Research Division
Douglas Schenkel – Wolfe Research, LLC
Mackenzie Strehle
Brendan Smith – TD Cowen, Research Division
Steven Etoch – Stephens Inc., Research Division
Presentation
Operator
Ladies and gentlemen, thank you for standing by. Welcome to Twist Bioscience Fiscal 2026 First Quarter Financial Results Conference Call. [Operator Instructions] Please be advised that today’s conference is being recorded. I would like now to turn the conference over to Angela Bitting, Senior Vice President of Corporate Affairs. Please go ahead.
Angela Bitting
Chief Corporate Responsibility Officer & Senior VP of Corporate Affairs
Thank you, operator. Good morning, everyone. I would like to thank you for joining us for Twist Biosciences conference call to review our fiscal 2026 first quarter financial results and business progress. We issued our financial results press release before the market, and it is available at our website at www.twistbioscience.com.
With me on the call today are Dr. Emily Leproust, CEO and Co-Founder of Twist; Adam Laponis, CFO of Twist; and Dr. Patrick Finn, President and COO of Twist. Today, we will discuss our business progress, financial and operational performance as well as growth opportunities. We will then open the call for questions. We ask that you limit your questions to only one and then requeue as a courtesy to others on the call. This call is being recorded. The audio portion will be archived in the Investors section of our website and will be available for 2 weeks.
Read the full article here
